4-(4-Chlorophenyl)-2-pyrrolidinone
CAS: 22518-27-0
Ref. TR-C379450
| 1mg | 185.00 € | ||
| 5mg | 555.00 € | ||
| 2500µg | 354.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Product Information
Name:
4-(4-Chlorophenyl)-2-pyrrolidinone
Controlled Product
Synonyms:
- 4-(p-Chlorophenyl)-2-pyrrolidinone
- 4-(4-Chlorophenyl)-2-pyrrolidone
- Baclofen Related Compound A
- Baclofen Imp. A (EP)
- (+/-)-Baclofen lactam
- Baclofen Related Compound A
- Baclofen Impurity A,(4RS)-4-(4-Chlorophenyl)pyrrolidin-2-one (Baclofen Lactam)
- (RS)-4-amino-3-(4-chlorophenyl)butyric acid lactam
- (±)-Baclofen lactam
- 2-Pyrrolidinone, 4-(4-Chlorophenyl)-
- See more synonyms
- 2-Pyrrolidinone, 4-(p-chlorophenyl)-
- 4-(4-Chlorophenyl)pyrrolidin-2-one
Description:
Impurity Baclofen EP Impurity A
Applications 4-(4-Chlorophenyl)-2-pyrrolidinone is used in the preparation of potential and selective antagonists of the α1A adrenergic receptor (1,2). It is an impurity of Baclofen (B108000), a specific GABA-B receptor agonist. Muscle relaxant (skeletal).
References (1) Whitlock, G. et al.: Bioorg. med. Chem. Lett., 19, 3118 (2009)(2) Brogden, R.N., et al.: Drugs, 8,1 (1974)
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
195.65
Formula:
C10H10ClNO
Color/Form:
White
InChI:
InChI=1S/C10H10ClNO/c11-9-3-1-7(2-4-9)8-5-10(13)12-6-8/h1-4,8H,5-6H2,(H,12,13)
InChI key:
InChIKey=OVRPDYOZYMCTAK-UHFFFAOYSA-N
SMILES:
O=C1CC(c2ccc(Cl)cc2)CN1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-C379450 4-(4-Chlorophenyl)-2-pyrrolidinone
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
